One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Factory Location: Xianyang, Shaanxi Province, China
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Monthly Production Capacity: 1000kg/month
Packaging Information: Double plastic bag inside, aluminum foil bag or fiber drum outside
Delivery Lead Time: in 7 days
Sample Provided: yes
Payment Terms: T/T, Paypal, L/C
Benfotiamine 99%
Type
Benfotiamine 99%
Form
Powder
Extraction Type
Solvent Extraction
Packaging
Drum, Aluminum Foil Bag
Place of Origin
China
Shaanxi
Grade
Food grade
Brand Name
QYHerb
Model Number
Benfotiamine
Application
Health Food
Service
24 hours
Product Name
Benfotiamine 99%
Appearance
White Powder
Certificate
ISO9001/Halal/Kosher/GMP
Shelf Life
2 Years
MOQ
1 Kilograms
Storage
Cool Dried Storage
Package
1kg/ Bag 25kg/drum
Specification
99%
Sample
Freee Sample 5-20g
OEM/ODM
Accepatable
Applications:
(1) For the prevention and treatment of vitamin B1 deficiency;
(2) It is used to supplement when the demand for vitamin B1 increases and the intake of vitamin B1 from food is insufficient (fatigue, hyperthyroidism, pregnancy, lactation, strenuous physical labor, etc.);
(3) For the treatment of non-alcoholic Wernicke encephalopathy;
(4) For the treatment of beriberi;
(5) For the treatment of the following diseases, speculated to be related to vitamin B1 deficiency and metabolic disorders, such as: neuralgia; Muscle pain, joint pain; Peripheral neuritis, peripheral nerve paralysis; Myocardial metabolism disorder; Constipation and other gastrointestinal motor dysfunction.
Entry book
Seven years of qualification
Audited Supplier
Pharma Sources Insight January 2025
